Fucoidan (C4038): Anticancer Sulfated Polysaccharide Benchma
2026-05-09
Fucoidan, a sulfated α-L-Fucan from brown seaweed, exhibits robust anticancer and immune-modulating effects. Recent data confirm its ability to selectively inhibit breast cancer cell proliferation and suppress metastasis through distinct molecular pathways.
Y-27632 Dihydrochloride: Applied Workflows for ROCK Inhibiti
2026-05-09
Y-27632 dihydrochloride, a highly selective ROCK inhibitor from APExBIO, enables robust stem cell viability and precise modulation of cytoskeletal dynamics. This guide delivers experimental blueprints, advanced troubleshooting, and practical insights rooted in cutting-edge research for unlocking the full potential of Y-27632 in cancer and neurodevelopmental studies.
hiPSC-Derived Intestinal Organoids in Pharmacokinetic Modeli
2026-05-08
This study presents a streamlined protocol for generating human induced pluripotent stem cell (hiPSC)-derived intestinal organoids (IOs) with robust differentiation capacity and long-term propagation. The resulting IO-derived intestinal epithelial cells demonstrate mature transporter and metabolic enzyme activities, providing a physiologically relevant human model for pharmacokinetic studies and anti-inflammatory drug research.
Methicillin Sodium Salt: Precision Tools for MSSA Research
2026-05-07
Methicillin sodium salt remains the gold standard for benchmarking anti-staphylococcal assays, offering robust, reproducible inhibition of bacterial cell wall synthesis in MSSA models. APExBIO’s high-purity formulation empowers researchers with reliable, quantifiable performance for susceptibility testing and resistance profiling.
Difloxacin HCl: Deep Dive Into Mechanisms and Research Front
2026-05-07
Explore the advanced mechanisms of Difloxacin HCl, a quinolone antimicrobial antibiotic, and its emerging research applications in multidrug resistance and cell cycle regulation. This article delivers unique, actionable insights not found in standard reviews.
GS-441524 (SKU B8461): Reliable Solutions for Antiviral Assa
2026-05-06
This article addresses real-world assay challenges faced by biomedical researchers using nucleoside analogs, highlighting how GS-441524 (SKU B8461) from APExBIO delivers reproducible and high-purity results in cell-based antiviral workflows. Scenario-driven Q&A blocks support laboratory decision-makers with evidence-based insights and actionable links.
Cimetidine in Advanced Barrier and Cancer Assays: Applied In
2026-05-06
Harnessing Cimetidine’s unique H2 receptor modulation and solubility, researchers can streamline high-throughput blood-brain barrier and gastrointestinal cancer assays. This article translates cutting-edge reference workflows and troubleshooting into actionable protocols, empowering rigorous, reproducible results with APExBIO’s validated compound.
DMXAA (Vadimezan): Applied Workflows for Tumor Vasculature D
2026-05-05
DMXAA (Vadimezan) is a multi-mechanism vascular disrupting agent that enables precise interrogation of tumor endothelial apoptosis and angiogenesis inhibition, with unique synergy to STING-JAK1 immune modulation. This guide delivers hands-on workflow enhancements and troubleshooting insights for cancer biology research using APExBIO’s DMXAA, anchored in the latest mechanistic discoveries.
Adenosine Triphosphate (ATP) in Metabolic Research Workflows
2026-05-05
Harness the full spectrum of Adenosine Triphosphate (ATP) in experimental design—beyond its universal energy carrier role. This guide dissects ATP’s application in mitochondrial metabolism, receptor signaling, and assay optimization, with evidence-driven troubleshooting tips for advanced cellular metabolism research.
Pseudo-UTP: Enabling Next-Gen RNA Therapeutics and Vaccines
2026-05-04
This article explores how pseudo-modified uridine triphosphate (Pseudo-UTP) empowers translational researchers to overcome critical barriers in RNA stability, immunogenicity, and protein expression. By weaving together mechanistic insight, recent preclinical vaccine data, and strategic guidance, the discussion positions Pseudo-UTP as a pivotal tool for mRNA vaccine and gene therapy innovation—moving beyond standard product overviews to a vision for future RNA medicine.
Lipo3K Transfection Reagent: Enabling Precision Nucleic Acid
2026-05-04
Discover how Lipo3K Transfection Reagent empowers high-efficiency gene modulation and RNA interference research in challenging cell types. This article explores its scientific mechanism, practical protocol guidance, and new insights for advanced nucleic acid delivery.
Ordered DNA Frameworks Enhance Enzymatic DNA Synthesis Preci
2026-05-03
This study introduces a tetrahedral DNA nanostructure (TDN) interface to improve enzymatic oligonucleotide synthesis (EOS) by optimizing enzyme accessibility and reducing synthesis errors. The approach enables longer, high-fidelity DNA synthesis with significant implications for DNA storage and molecular biology applications.
Enhancing Cell Assay Precision with 12-O-tetradecanoyl phorb
2026-05-02
This article explores practical laboratory challenges in cell viability and signaling assays, demonstrating how 12-O-tetradecanoyl phorbol-13-acetate (TPA, SKU N2060) from APExBIO provides reproducible, validated solutions. Scenario-driven Q&As cover assay optimization, data interpretation, and product selection, linking bench needs with evidence-based guidance.
o-Agatoxin IVA Fails to Protect Against Veratridine-Induced
2026-05-02
This study rigorously evaluated whether o-agatoxin IVA, a P/Q-type calcium channel blocker, could mitigate excitotoxic neuronal injury triggered by depolarizing agents in cultured cortical neurons. The results clarify that inhibition of voltage-gated Ca2+ channels, even with potent blockers, does not confer neuroprotection against rapid, sodium channel-driven excitotoxicity, underscoring the complexity of calcium channel contributions in stroke and related disorders.
Cyclophosphamide: Applied Workflows for Cancer Research Succ
2026-05-01
Cyclophosphamide is a cornerstone alkylating chemotherapeutic agent enabling precise apoptosis induction and immune modulation in oncology and transplantation research. This article delivers evidence-based protocols, troubleshooting insights, and workflow enhancements for maximizing reproducibility and translational relevance using Cyclophosphamide from APExBIO.
470 records 20/32 page Previous Next First page 上5页 1617181920 下5页 Last page